Myriad Genetics, Inc. (MYGN) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Myriad Genetics, Inc. (MYGN)

An SI Board Since August 1996

Posts	SubjectMarks	Bans	Symbol
2355	65	0	MYGN

Emcee: s myers	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1205	>> The trend shows AD lottery ticket still in play. << Yeah......	scaram(o)uche	-	5/2/2005
1204	The analysts wrote comments about the trial being pivotal, so they expected sign	Lee39	-	5/2/2005
1203	Just what most of us expected. Trends look pretty good. Jon	Robohogs	-	5/2/2005
1202	Myriad Genetics Reports Results of Phase 2 Trial of Flurizan(TM) in Patients Wit	mopgcw	-	5/2/2005
1201	Synapse. 2005 Apr 27;57(1):1-7 [Epub ahead of print] Intrastriatal dopamine D1	scaram(o)uche	-	4/29/2005
1200	J Virol. 2005 May;79(10):6392-9. Identification of domains in gag important fo	scaram(o)uche	-	4/29/2005
1199	That's my guess, too. Think buying in after flurbie PII results is a good s	tuck	-	4/28/2005
1198	The Board has been lazy and generous.	scaram(o)uche	-	4/28/2005
1197	Thanks for the clarification. As you posted before, MYGN PM business and oncolog	Lee39	-	4/28/2005
1196	nobody can answer that question. care givers are convinced that it works. it&#	scaram(o)uche	-	4/28/2005
1195	I've seen them take shots at other companies. To be expected, given who is	scaram(o)uche	-	4/28/2005
1194	> flurbiprofen and an NO-donating derivative of flurbiprofen (HCT 1026) the a	Lee39	-	4/28/2005
1193	Brean Murray starts mygn at a sell. Looking back on where the stock has come fr	keokalani'nui	-	4/28/2005
1192	Peter Meldrum: Let me know if we have a deal, please. I can sell shares to a p	scaram(o)uche	-	4/28/2005
1191	There are some simple fundamentals. Number one?... development stage biotech	scaram(o)uche	-	4/28/2005
1190	Peter Meldrum: I consider it one of the all-time slimeball occupations..... n	scaram(o)uche	-	4/28/2005
1189	Rick, Thanks and thanks also for the kind words on the SEPR board. Jon	Robohogs	-	4/28/2005
1188	Peter Meldrum: Your salary, given your insights, is SILLY BIG in comparison to	scaram(o)uche	-	4/28/2005
1187	>> Does this new paper indicates the chance of AD Ph 2 trial hitting stati	scaram(o)uche	-	4/28/2005
1186	Jon: I've been trying to answer your question, but I'm getting constant	scaram(o)uche	-	4/28/2005
1185	>>don't know their affiliation [the Finnish team]<< Their affil	sim1	-	4/28/2005
1184	What are your expectations for the trial results? Jon PS I expect trending bu	Robohogs	-	4/28/2005
1183	One other thing: we don't know the doses the Finnish team (don't know th	tuck	-	4/28/2005
1182	>>Does this new paper indicates the chance of AD Ph 2 trial hitting statis	tuck	-	4/28/2005
1181	Rick, Readint the excerpts, it comes to mind - How good is the MYGN IP position	Robohogs	-	4/28/2005

Go to reply# or date (mm/dd/yy):